Securities code: 301087 securities abbreviation: Cofoe Medical Technology Co.Ltd(301087)
Cofoe Medical Technology Co.Ltd(301087)
Record of investor relations activities
No.: 2022-003
Investor relations activity category □ specific object research □ analyst meeting
□ media interview □ performance briefing
□ press conference □ Roadshow
□ site visit
□ other conference calls
Name of participating unit and personnel Haitong Securities Company Limited(600837) Meng Lu; Tianhong fund song Peng; Dacheng Fund Zou Jian and Chen Quanlong; China Europe Fund Glenn; Name: Sui Yi of Xingquan fund; Sun Haoyang of Yinhua Fund; Ping An fund Xu Wangyang; Harvest Fund sun Xiaohui; Huabao fund Qi Zhen and Wei Yangfan; Soochow Securities Co.Ltd(601555) Wang Lan; Wu Yu Yanqiu; CCB fund Zheng Dingyuan; Jiahe fund chaisen; Zhengyuan investment Qi Chen and Zhong Xiaolin; China Industrial Securities Co.Ltd(601377) sun Yuanyuan, Wang Jiahui, Jili; Li Xiaoxing, Zhang Ping and Wang Lu of Yinhua Fund; Dongzheng asset management Jiang Qi; Orient Securities Company Limited(600958) Li Feng.
Time: from January 17, 2022 to January 21, 2022
Location Cofoe Medical Technology Co.Ltd(301087) conference room
Name of receptionist of listed company
Director / Vice President / Secretary Xue Xiaoqiao
name
1. What is the progress of the company’s acquisition of back good business integration?
A: on the one hand, the company is promoting the asset restructuring, audit and evaluation of the acquisition target according to the terms and agreements signed in the early stage; On the other hand, the business teams of both sides are closely connected to carry out the handover of online stores.
In addition, the company has established a joint scientific and technological innovation center with the Second Xiangya Hospital of Central South University to launch the application and R & D project of pressure sensing intelligent chest and back correction devices based on the main device learning of machine investor relations activities. Through clinical evaluation, the company continuously introduces and optimizes the intelligent adjustment chest and back correction devices and reshapes the brand definition.
2. What are the reasons for the increase in sales expenses of Beijia?
A: the main reason is that in the first half of 2021, the back to back operation team increased its attempts to use new sales strategies and used some new drainage and promotion tools. The proportion of promotion expenses such as through train and pinxiaobao increased. In the second half of the year, the operation team adjusted the marketing strategy and the expense rate gradually returned to the normal level.
The company’s Internet sales channels are highly overlapped with its back-to-back good sales channels. Based on the company’s strong e-commerce operation ability, by optimizing marketing strategy and improving pre-sales and after-sales service level and warehouse management ability, the company can greatly reduce operation costs, warehouse logistics costs and improve profitability. At the same time, based on the company’s perfect sales system, we can quickly introduce the business of beibeijia into offline channels and sell through national pharmacy customers and supermarkets, so as to make up for the gap of the current offline channels and increase the offline sales revenue.
3. What is the reason for the low gross profit margin of giri medical?
A: compared with other categories of products, the gross profit rate of rehabilitation products is lower than that of other categories. At the same time, the relocation of giri medical production base from Shanghai to Nantong in 2021 resulted in the increase of some production costs and the increase of unit labor cost in the short term.
With the further deepening of aging and the upgrading of economic development and consumption, electric wheelchairs have developed rapidly in recent years. There is still much room for the replacement rate of electric wheelchairs for traditional manual wheelchairs. In the future, the company will increase R & D investment and improve product scientific and technological strength and user experience. There is still room to improve the gross profit margin of electric wheelchairs. On the whole, the future development prospect of electric wheelchairs industry is good.
4. According to the company’s equity incentive plan, the revenue growth in 2022 is currently 30%. In addition to normal business growth, what are the driving factors of the company’s channel end this year?
A: tiktok Kwai is expected to achieve steady growth as the company continues to upgrade its operations and develop new business platforms such as jitter, fast track, group purchase, hungry group and community group buying.
In the offline business segment, with the increase of the company’s independent production proportion and brand influence, more Chinese chain pharmacies deepen their cooperative relations with the company, and the company’s products are settled in more offline pharmacies, which will boost the rapid growth of offline business in the future.
In addition, the company’s two M & A businesses, as well as the development of overseas market and hospital market, will also bring certain increment to the company.
5. Is the company’s agency business gradually reduced?
A: in recent years, the company has continuously increased its investment in technology R & D and manufacturing, improved the types and production capacity of self-produced products, and further increased the proportion of self-produced products, resulting in the decline of the proportion of agency business income of the company year by year, which is in line with the development law of the industry and the development plan of the company, and is reasonable.
6. Recently, the state has issued some support policies for traditional Chinese medicine. Does it promote traditional Chinese medicine physiotherapy products? A: at present, China is vigorously promoting the development of traditional Chinese medicine, which will have some conduction effects on the company’s traditional Chinese medicine physiotherapy products. In the future, with the sound development of traditional Chinese medicine service system, it will bring new development opportunities for traditional Chinese medicine physiotherapy products. The company will also seize the opportunities, increase R & D and technological innovation, and broaden the development space in the field of traditional Chinese medicine physiotherapy.
7. What are the key R & D areas of the company in the future?
A: the company established three research institutes this year. Through diversified cooperation with research institutions and think tanks at home and abroad, the company is committed to the exploration and research of multiple application fields and product types such as rehabilitation medicine, vital signs and biosensor.
The research interests of medical electronics and Rehabilitation Medicine Research Institute include hearing, rehabilitation medicine, respiratory support and life information detection; The research direction of the Institute of biosensor and innovative materials covers in vitro diagnostic product series, intelligent Wearable ECG monitoring series, high-end medical biomaterials, killing sensing and control materials, health protection and nursing materials, etc; Shenzhen Research Institute mainly focuses on the innovative R & D and production of continuous blood glucose monitoring system and other products.
8. What are the main aspects of the company’s online channel capabilities?
A: as an early enterprise in China that has obtained the Internet B2B and B2C trading license for medical devices, the company has accumulated many years of online operation experience, and the scale of operation team is at a high level in the industry.
In terms of e-commerce operation management, the company’s operation team coordinates the operation, including store decoration, commodity management, production and upload of commodity page details, event planning, event implementation, traffic expansion, channel construction, customer service, order delivery, return and exchange processing, consumer complaint processing, etc. through fine management and resource investment, The company’s online sales and accumulated users have increased steadily, and the “Kefu” brand has established a high brand recognition and good market reputation.
9. How does the company layout its overseas market?
A: overseas business is mainly divided into to B end and to C end. On the one hand, the company has established an international business department to build an overseas business team, layout and improve the overseas sales network. At the same time, the company is also stepping up product registration. Some products have been certified by FDA and CE of the European Union. In the future, with the further improvement of the company’s self-production capacity, the categories of export products will further increase; On the other hand, the company has gradually settled in cross-border e-commerce platforms such as Maitong, lazada, shopee and Amazon, continuously improved the construction of overseas platforms, improved platform operation capacity and helped overseas user growth projects.
10. Source of sales of hearing aids in Jianer stores and the company’s hearing aid R & D plan?
A: Jianer store is positioned at the middle and high-end hearing aid fitting. It mainly acts as an agent for international brands and provides customers with professional integrated hearing aid fitting services. The company has developed audiometry equipment and hearing aid products for many years. The self-developed wireless rechargeable hearing aid and pure tone audiometer were awarded the honor of Innovation Medical Management Co.Ltd(002173) device in Hunan Province in 2018 and 2019 respectively. At present, the company has launched a number of medium and low-end digital hearing aid products and sold them in Online channels and local offline stores. At the same time, the company is actively carrying out product R & D of real ear analyzer, multi-channel hearing aid and high-end digital customization machine, opening up the closed loop of the industrial chain from hearing test equipment, hearing aid product R & D and production, hearing aid fitting service, and establishing its own competitive advantage.
11. Training cycle and difficulty of matching teachers?
A: a senior hearing aid fitter should have solid professional knowledge of audiology, debugging technology and professional quality, and be able to help the hearing impaired choose suitable hearing aids through professional hearing testing according to the hearing loss status of customers and their own hearing needs, And provide professional and reasonable solutions for the later use of hearing aids and rehabilitation of hearing impaired people. The training of the company’s matchmaker is divided into three levels: primary, intermediate and senior matchmaker training. At the same time, the matchmaker has a daily self-study plan and weekly assessment.
For new employees, the company organizes a closed training for about one month, including hearing consultation, hearing testing, hearing aid selection, impression sampling, hearing aid debugging, effect evaluation, rehabilitation guidance and store operation. After a certain period of practice in the store, the company will organize intensive training. At the same time, the company will regularly organize training courses for senior fitting technicians to quickly enrich the team of hearing aid fitting engineers through hierarchical training and old and new forms. At present, the company is exploring the establishment of a joint training base for fitting teachers with well-known universities in China, and plans to invite well-known otolaryngology experts in China to conduct higher-level training for fitting teachers.
Annex list (if any) none
Date: January 21, 2022
